Bard Associates’s Alerian MLP ETF AMLP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.9M Sell
171,562
-1,120
-0.6% -$58.8K 1.97% 13
2026
Q1
$9.09M Buy
172,682
+155
+0.1% +$7.89K 2.28% 11
2025
Q4
$8.11M Buy
172,527
+71,446
+71% +$3.34M 2.08% 10
2025
Q3
$4.74M Buy
101,081
+89,527
+775% +$4.33M 1.26% 30
2025
Q2
$565K Buy
11,554
+530
+5% +$25.7K 0.18% 113
2025
Q1
$573K Buy
11,024
+889
+9% +$45.6K 0.21% 112
2024
Q4
$488K Buy
10,135
+1,912
+23% +$91.9K 0.17% 120
2024
Q3
$388K Buy
+8,223
New +$389K 0.13% 137

Other funds holding AMLP

Bard Associates's AMLP Position: Q2 2026 in Review

Bard Associates reduced its Alerian MLP ETF (AMLP) stake by 0.65% in Q2 2026, selling an estimated $58.8K and leaving 171,562 shares worth $8.9M. The position accounts for 1.97% of the portfolio, ranked #13.

Bard Associates first reported a position in AMLP in Q3 2024 and has held it in 8 quarters since. The position peaked at $9.09M in Q1 2026. 808 funds tracked by Wall St. Rank hold AMLP as of Q2 2026.

  • Bard Associates held 171,562 shares of Alerian MLP ETF worth $8.9M as of Q2 2026.
  • Bard Associates sold 1,120 Alerian MLP ETF shares in Q2 2026, an estimated $58.8K.
  • Alerian MLP ETF made up 1.97% of Bard Associates's portfolio in Q2 2026, its #13 holding.
  • Bard Associates first reported a position in Alerian MLP ETF in Q3 2024 and has held it in 8 quarters since.
  • Bard Associates's Alerian MLP ETF position peaked at $9.09M in Q1 2026.
  • 808 funds tracked by Wall St. Rank held Alerian MLP ETF as of Q2 2026.

Based on Bard Associates's 13F filing for Q2 2026, filed 12 Aug 2026.